Roland Rick Perry Sunday, 07/28/19 11:09:25 AM Re: None Post # of 60 Interesting. Studying now, read enough to add to Watch List - with the low market cap and recent price action, what's not to like. Wasn't aware of the severity of CVS. We embedded a cool video from the Cleveland Clinic on our site. http://internetstockreview.com/biotech-stock-review-adds-hancock-jaffe-hjli-1-05-to-watch-list/ Noticed Tailwinds is following. We both initiated coverage on Dyadic (DYAI) around the same time and price ($1.30) in 2017 before its nice run to $7.00. Not, as they say, is past performance any indication of future performance!